10-Q: Healthcare Integrated Technologies Reports First Revenue and Strategic Alliance in Q2 2024

Sentiment:

Quarterly Report


Healthcare Integrated Technologies reports its first revenue and a strategic alliance with Signature HealthCARE in its second quarter of fiscal year 2024.

Delay expectedThe 5% convertible promissory notes are in default, indicating a delay in repayment.The note payable to Acorn Management Partners, LLC is also in default, indicating a delay in repayment.
Capital raiseThe company intends to finance its future activities and working capital needs largely from the sale of private and/or public equity securities.The company is likely to continue using short-term loans from management to meet its short-term funding needs.
Worse than expectedThe company's financial results were worse than expected due to the significant net loss and working capital deficit.The company's revenue was minimal, and the company is still in the early stages of commercialization.The company's debt obligations are in default, which is a significant negative indicator.

Summary

  • Healthcare Integrated Technologies, Inc. reported its financial results for the quarter ended January 31, 2024, showing its first revenue of $21,769.
  • The company's operating expenses totaled $163,727, which included $104,137 in selling, general, and administrative costs, $3,893 in stock-based compensation, and $55,697 in amortization of intangibles.
  • The company experienced an operating loss of $141,958 and a net loss of $155,163 for the quarter.
  • For the six months ended January 31, 2024, the company's net loss was $383,663.
  • The company's cash and cash equivalents stood at $315,779 as of January 31, 2024.
  • The company has a working capital deficit of $1,681,734.
  • The company entered into a strategic alliance with Signature HealthCARE and secured contracts for its SafeFace product, generating its first revenue.
  • The company is also exploring a potential acquisition of Glass 8 Holdings LLC.

Sentiment

Score: 3

Explanation: The document reveals significant financial challenges, including a substantial net loss, working capital deficit, and debt defaults. While there are positive developments such as the first revenue and strategic alliance, the overall financial health and going concern issues raise serious concerns.

Positives

  • The company generated its first revenue of $21,769, marking a significant milestone.
  • The strategic alliance with Signature HealthCARE provides a platform for pilot testing and potential deployment of the company's products.
  • The $266,000 contract with Signature provides a solid revenue stream.
  • The contingent fee contract with Signature offers potential for additional revenue based on cost savings.
  • The company is actively pursuing acquisitions to expand its business.

Negatives

  • The company reported a net loss of $155,163 for the quarter and $383,663 for the six months ended January 31, 2024.
  • The company has a significant working capital deficit of $1,681,734.
  • The company has a history of losses and an accumulated deficit.
  • The company's independent auditor has raised substantial doubt about its ability to continue as a going concern.
  • The company's 5% convertible promissory notes with a face value of $175,000 are in default.
  • The note payable to Acorn Management Partners, LLC is also in default.

Risks

  • The company's ability to continue as a going concern is dependent on securing additional funding.
  • The company's financial condition is weak, with a history of losses and a significant working capital deficit.
  • The company's ability to generate sufficient revenue and control costs is uncertain.
  • The company's debt obligations are in default, which could lead to further financial difficulties.
  • The company's reliance on related party loans and advances poses a risk.
  • The company's internal controls over financial reporting are not effective.

Future Outlook

The company intends to finance its future activities and working capital needs through the sale of private and/or public equity securities and other traditional financing sources. The company is also actively pursuing acquisitions to advance its acquisition strategy.

Management Comments

  • The management team is focused on maintaining financial flexibility and assembling the right personnel to execute the company's mission.
  • The company is focused on its core product, continuing the development of its proprietary software, and developing new uses and product lines for its technology.

Industry Context

The company operates in the healthcare technology sector, focusing on solutions for continuing care, home care, and professional healthcare spaces. The strategic alliance with Signature HealthCARE aligns with the industry trend of adopting technology to improve patient care and operational efficiency.

Comparison to Industry Standards

  • The company's revenue of $21,769 is very low compared to established healthcare technology companies, which often report millions or billions in revenue.
  • The company's net loss of $383,663 for the six months ended January 31, 2024 is typical for early-stage technology companies that are still in the development and pilot testing phase.
  • The company's working capital deficit of $1,681,734 is a significant concern and is not typical for established companies in the healthcare technology sector.
  • The company's reliance on related party loans and advances is not uncommon for early-stage companies but is not a sustainable long-term financing strategy.
  • The company's strategic alliance with Signature HealthCARE is a positive step, but its success will depend on the successful implementation and adoption of its products.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Executive OfficernaScott M. Boruff2023-08-01New appointment under a Non-Employee Chief Executive Officer Engagement Agreement
Chief Financial OfficernaCharles B. Lobetti, III2023-08-01New appointment under an employment agreement
Chief Technology OfficernaKenneth M. Greenwood2023-08-01New appointment under an employment agreement
Chief Medical OfficernaSusan A. Reyes, MD2023-08-01New appointment under an employment agreement

Related Party Transactions

  • The company has entered into several related party transactions, including loans from related parties and a Non-Employee Chief Executive Officer Engagement Agreement with Platinum Equity Advisors, LLC.
  • The spouse of the CEO controls a 37.775% membership interest in Glass 8 Holdings LLC, which the company is considering acquiring.

Stakeholder Impact

  • Shareholders face significant risk due to the company's financial instability and going concern issues.
  • Employees may be impacted by the company's financial difficulties and potential restructuring.
  • Customers may be affected by the company's ability to deliver its products and services.
  • Creditors face the risk of non-payment due to the company's debt defaults.

Next Steps

  • The company will continue to evaluate its new products, SafeFace and SafeGuard.
  • The company will implement pilot programs with Signature HealthCARE.
  • The company will continue to pursue acquisitions to advance its acquisition strategy.
  • The company will seek additional funding through the sale of equity securities and other financing sources.
  • The company will negotiate amendments to the defaulted notes.

Key Dates

DateDescription
2018-03-01Issuance of 5% Convertible Promissory Notes began.
2020-08-11Agreement to repurchase shares from Acorn Management Partners, LLC and issuance of a promissory note.
2022-08-26Consulting agreement with G. Shayne Bench and Bucuti Investments, LLC.
2023-06-12Issuance of Promissory Note to Platinum Equity Advisors, LLC.
2023-08-01Effective date of Non-Employee Chief Executive Officer Engagement Agreement and employment agreements for CFO, CTO, and CMO.
2023-08-08Announcement of strategic alliance with Signature HealthCARE.
2023-12-01Contracts with Signature to install SafeFace software.
2023-12-12Issuance of new promissory note to Platinum Equity Advisors, LLC.
2024-01-31End of the reporting period for the quarterly report.
2024-03-18Date of filing of the quarterly report.

Keywords

Healthcare Technology, AI, Fall Detection, Senior Care, Strategic Alliance, Revenue, Financial Results, Acquisition, SafeSpace, SafeFace, SafeGuard

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.